BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 2104254)

  • 41. Mechanisms of ciclosporin A-induced vasoconstriction in the isolated perfused rat kidney.
    Mehring N; Neumann KH; Rahn KH; Zidek W
    Nephron; 1992; 60(4):477-81. PubMed ID: 1584325
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Direct visualization of effects of endothelin on the renal microvasculature.
    Loutzenhiser R; Epstein M; Hayashi K; Horton C
    Am J Physiol; 1990 Jan; 258(1 Pt 2):F61-8. PubMed ID: 2405711
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Endothelin: a potent renal and systemic vasoconstrictor peptide.
    King AJ; Brenner BM; Anderson S
    Am J Physiol; 1989 Jun; 256(6 Pt 2):F1051-8. PubMed ID: 2660593
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Endothelin induces an increase in renal vascular resistance and a fall in glomerular filtration rate in the rabbit isolated perfused kidney.
    Cairns HS; Rogerson ME; Fairbanks LD; Neild GH; Westwick J
    Br J Pharmacol; 1989 Sep; 98(1):155-60. PubMed ID: 2679955
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Effect of therapeutic doses of cyclosporine injected into the renal and femoral arteries in dogs].
    Tronc F; Carrier M; Pelletier LC
    Ann Chir; 1991; 45(9):827-32. PubMed ID: 1664194
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cyclosporine-induced acute renal dysfunction in the rat. Evidence of arteriolar vasoconstriction with preservation of tubular function.
    English J; Evan A; Houghton DC; Bennett WM
    Transplantation; 1987 Jul; 44(1):135-41. PubMed ID: 3603674
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cyclosporine A directly constricts intrarenal arterioles.
    Abraham JS; Bentley FR; Garrison RN; Cryer HM
    Transplant Proc; 1991 Feb; 23(1 Pt 1):356-9. PubMed ID: 1990551
    [No Abstract]   [Full Text] [Related]  

  • 48. Pentoxifylline decreases cyclosporine-induced renal endothelin release and vasoconstriction.
    Carrier M; Perrault LP; Tronc F; Stewart DJ; Pelletier CL
    Ann Thorac Surg; 1993 Feb; 55(2):490-2. PubMed ID: 8431065
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Glomerular actions of endothelin in vivo.
    Kon V; Yoshioka T; Fogo A; Ichikawa I
    J Clin Invest; 1989 May; 83(5):1762-7. PubMed ID: 2651481
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prevention of cyclosporine A-induced renal vasoconstriction by the endothelin receptor antagonist SB 209670.
    Brooks DP; Contino LC
    Eur J Pharmacol; 1995 Dec; 294(2-3):571-6. PubMed ID: 8750720
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Influence of the rate of infusion on cyclosporine nephrotoxicity in the rat.
    Finn WF; McCormack AJ; Sullivan BA; Hak LJ; Clark RL
    Ren Fail; 1989; 11(1):3-15. PubMed ID: 2772285
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Use of the isolated perfused kidney model to assess the acute pharmacologic effects of cyclosporine and its vehicle, cremophor EL.
    Besarab A; Jarrell BE; Hirsch S; Carabasi RA; Cressman MD; Green P
    Transplantation; 1987 Aug; 44(2):195-201. PubMed ID: 3629683
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Acute cyclosporine-induced renal vasoconstriction: lack of effect of theophylline.
    Churchill PC; Rossi NF; Churchill MC; Bidani AK; McDonald FD
    Am J Physiol; 1990 Jan; 258(1 Pt 2):F41-5. PubMed ID: 2301595
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Endothelin: an important factor in acute renal failure?
    Firth JD; Ratcliffe PJ; Raine AE; Ledingham JG
    Lancet; 1988 Nov; 2(8621):1179-82. PubMed ID: 2903385
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cyclosporine promotes glomerular endothelin binding in vivo.
    Awazu M; Sugiura M; Inagami T; Ichikawa I; Kon V
    J Am Soc Nephrol; 1991 May; 1(11):1253-8. PubMed ID: 1657241
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cyclosporine A toxicity is associated with reduced endothelin immunoreactivity in renal endothelium.
    Watschinger B; Ulrich W; Vychytil A; Traindl O; Seidl S; Kainz H; Klauser R; Wamser P; Kovarik J
    Transplant Proc; 1992 Dec; 24(6):2618-9. PubMed ID: 1465886
    [No Abstract]   [Full Text] [Related]  

  • 57. Effectiveness of enalapril versus nifedipine to antagonize blood pressure and the renal response to endothelin in humans.
    Kaasjager KA; Koomans HA; Rabelink TJ
    Hypertension; 1995 Apr; 25(4 Pt 1):620-5. PubMed ID: 7721406
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The renal hemodynamic response to endothelin in chronic cyclosporine-treated dogs.
    Fisch J; Gulmi FA; Chou SY; Mooppan UM; Kester RR; Kim H
    J Urol; 1993 Apr; 149(4):878-83. PubMed ID: 8455268
    [TBL] [Abstract][Full Text] [Related]  

  • 59. In vitro effects of cyclosporine on glomerular function.
    Wiegmann TB; Sharma R; Diederich DA; Savin VJ
    Am J Med Sci; 1990 Mar; 299(3):149-52. PubMed ID: 2316558
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A role for endothelin in the maintenance of post-ischaemic renal failure in the rat.
    López-Farré A; Gómez-Garre D; Bernabeu F; López-Novoa JM
    J Physiol; 1991 Dec; 444():513-22. PubMed ID: 1822562
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.